Header cover image

Canadian (TSX) Biotech Industry Analysis

UpdatedJul 20, 2024
DataAggregated Company Financials
Companies32
  • 7D-5.2%
  • 3M-6.2%
  • 1Y-41.1%
  • YTDn/a

Over the last 7 days, the Biotech industry has dropped 3.6%, driven by a pullback from ME Therapeutics Holdings of 23%. Meanwhile, Medicenna Therapeutics actually outperformed within the industry, gaining 8.2% in the last week. However, the industry is down 41% over the past year. As for the next few years, earnings are expected to grow by 49% per annum.

Industry Valuation and Performance

Has the Canadian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 20 Jul 2024CA$1.1bCA$76.1m-CA$339,684,577.8011.3x-3.2x14.3x
Mon, 17 Jun 2024CA$1.2bCA$76.9m-CA$340,271,341.4610.9x-3.4x15x
Wed, 15 May 2024CA$1.1bCA$78.6m-CA$345,311,677.5011.8x-3.1x13.6x
Fri, 12 Apr 2024CA$911.8mCA$80.7m-CA$299,139,762.1711.9x-3x11.3x
Sun, 10 Mar 2024CA$1.1bCA$91.6m-CA$319,845,520.8010.9x-3.5x12.1x
Tue, 06 Feb 2024CA$1.0bCA$87.8m-CA$340,044,596.869.4x-3x11.6x
Thu, 04 Jan 2024CA$3.6bCA$86.2m-CA$515,808,070.007x-7x42.1x
Sat, 02 Dec 2023CA$3.8bCA$86.0m-CA$542,278,469.005.2x-6.9x43.7x
Mon, 30 Oct 2023CA$3.7bCA$89.1m-CA$538,186,417.007.4x-6.9x41.7x
Wed, 27 Sep 2023CA$3.9bCA$88.8m-CA$530,382,953.005.7x-7.3x43.8x
Fri, 25 Aug 2023CA$4.0bCA$87.3m-CA$510,014,920.006.4x-7.8x45.4x
Sun, 23 Jul 2023CA$4.0bCA$81.5m-CA$516,542,925.0013.4x-7.8x49.5x
Tue, 20 Jun 2023CA$3.9bCA$86.4m-CA$543,179,028.0012.6x-7.2x45.4x
Thu, 18 May 2023CA$3.7bCA$82.8m-CA$604,425,934.0011.4x-6.1x44.9x
Sat, 15 Apr 2023CA$2.4bCA$83.7m-CA$592,548,475.0012x-4x28.4x
Mon, 13 Mar 2023CA$2.6bCA$90.6m-CA$588,799,451.007.9x-4.5x29.2x
Wed, 08 Feb 2023CA$3.1bCA$91.4m-CA$589,363,639.0011.9x-5.2x33.5x
Fri, 06 Jan 2023CA$3.0bCA$87.6m-CA$528,585,057.0011.3x-5.7x34.5x
Sun, 04 Dec 2022CA$3.4bCA$88.5m-CA$576,460,852.007.1x-5.8x38x
Tue, 01 Nov 2022CA$3.1bCA$86.1m-CA$568,239,838.0013x-5.4x35.5x
Thu, 29 Sep 2022CA$3.4bCA$85.4m-CA$548,948,638.0013x-6.1x39.3x
Sat, 27 Aug 2022CA$3.5bCA$86.0m-CA$534,783,175.0013.9x-6.6x40.8x
Mon, 25 Jul 2022CA$3.2bCA$87.3m-CA$564,803,552.0010.5x-5.6x36.3x
Wed, 22 Jun 2022CA$3.0bCA$181.6m-CA$610,019,163.0012.4x-5x16.7x
Fri, 20 May 2022CA$3.2bCA$180.0m-CA$455,664,263.009.8x-7.1x18x
Sun, 17 Apr 2022CA$3.6bCA$175.1m-CA$487,440,146.0015.1x-7.3x20.4x
Tue, 15 Mar 2022CA$3.1bCA$171.7m-CA$471,422,725.0013.3x-6.6x18x
Thu, 10 Feb 2022CA$3.6bCA$167.4m-CA$449,011,163.0017.9x-8x21.4x
Sat, 08 Jan 2022CA$3.6bCA$167.3m-CA$432,496,012.0020.5x-8.4x21.8x
Mon, 06 Dec 2021CA$5.7bCA$172.9m-CA$503,991,712.005x-11.2x32.8x
Wed, 03 Nov 2021CA$8.1bCA$244.8m-CA$612,749,932.008.4x-13.2x33x
Fri, 01 Oct 2021CA$8.1bCA$241.9m-CA$611,874,642.007.2x-13.2x33.5x
Sun, 29 Aug 2021CA$5.1bCA$161.7m-CA$473,092,915.0832.3x-10.8x31.7x
Price to Earnings Ratio

-7.4x


Total Market Cap: CA$3.5bTotal Earnings: -CA$474,887,008.08Total Revenue: CA$161.7mTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Biotech Industry Price to Earnings3Y Average -6.7x202220232024
Current Industry PE
  • Investors are pessimistic on the Canadian Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 31.0x is higher than the industry's current PS ratio of 14.9x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 22% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Comparison

How does Canadian Biotech compare with similar industries?

CA Market0.029%
Healthcare-0.21%
Biotech-5.23%
Biotech-5.23%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TH TheratechnologiesCA$2.159.1%
+CA$8.3m
-38.9%PS0.9x
TTI Thiogenesis TherapeuticsCA$0.7820.0%
+CA$5.9m
20.0%PB6.6x
MBX Microbix BiosystemsCA$0.348.1%
+CA$3.4m
8.1%PE11.3x
RVX ResverlogixCA$0.0620.0%
+CA$2.8m
-40.0%PE-1.2x
AWKN Awakn Life SciencesCA$0.1241.2%
+CA$1.4m
-53.8%PS50.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SVA

CA$0.28

Sernova

7D

-8.2%

1Y

-70.5%

MSCL

CA$0.47

Satellos Bioscience

7D

-6.0%

1Y

6.8%

TH

CA$2.15

Theratechnologies

7D

9.1%

1Y

-38.9%

EPRX

CA$3.43

Eupraxia Pharmaceuticals

7D

-7.3%

1Y

-54.8%

EDT

CA$0.48

Spectral Medical

7D

-6.7%

1Y

56.5%

AWKN

CA$0.12

Awakn Life Sciences

7D

41.2%

1Y

-53.8%

MDNA

CA$1.90

Medicenna Therapeutics

7D

-11.2%

1Y

239.3%

SBM

CA$0.045

Sirona Biochem

7D

12.5%

1Y

-57.1%

ACOG

CA$0.70

Alpha Cognition

7D

-7.9%

1Y

89.2%

RVX

CA$0.06

Resverlogix

7D

20.0%

1Y

-40.0%

MBX

CA$0.34

Microbix Biosystems

7D

8.1%

1Y

8.1%

CYTO

CA$0.30

Cytophage Technologies

7D

-15.5%

1Y

n/a

PSYG

CA$0.015

Psyence Group

7D

50.0%

1Y

-88.5%

GLAB

CA$0.46

Gemina Laboratories

7D

2.2%

1Y

2.2%

METX

CA$3.75

ME Therapeutics Holdings

7D

-6.3%

1Y

n/a